Charterhouse Partners With Tunstall for Future Growth

TunstallTunstall Group, the market leading provider of telecare and telehealth solutions, has undertaken an extensive strategic review of its business, and has found an excellent new partner in Charterhouse Capital Partners, further strengthening the Group's future growth plans.

Charterhouse is a successful British business with a 30-year track record and is committed to backing the Tunstall management team to achieve its vision. They join Bridgepoint, Tunstall's previous majority shareholder, who become a minority shareholder in the business.

Tunstall's solutions support over 2.5 million people worldwide allowing them to live independently, by effectively managing their health and well-being. Telecare is increasingly recognised as being at the heart of modern health and social care systems and Tunstall's aim is to deliver a broader range of services to effectively assist more people by providing flexible, timely, and proactive support.

James Buckley, Chief Executive, Tunstall Group said, "I am delighted to be working with Charterhouse to realise our vision of improving the quality of life for many more people in the future. Telecare plays a key role in delivering personalised care to support people with health and social care needs, their families and carers. Our aim is to offer even more enhanced levels of support, drive forward our technology plans and work with our customers to provide effective solutions for a diverse range of people across the globe and I believe we have found the right team to help us achieve our ambitions."

Jeremy Greenhalgh, Partner, Charterhouse added "It is clear that Tunstall is a very successful business with attractive solutions in a market that is experiencing ageing demographics and the emergence of lifestyle epidemics such as obesity and chronic disease. Governments around the world are recognising the compelling economics of telecare and telehealth and I am looking forward to working with the team to deliver its plans for the future."

Related news articles:

About Tunstall
Tunstall is the market leading provider of telecare and telehealth solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives. For more information on how telecare and telehealth can improve quality of life, visit www.tunstall.co.uk.

About Charterhouse
Charterhouse Capital Partners leads and invests in large European buy-outs and has been doing so since the early days of the buy-out market in the 1980's. With over 128 transactions, worth an aggregate €38bn in transaction value, and with 89% of those investments realised, we believe that our track record and experience combine to make us one of the most successful private equity firms in Europe. www.charterhouse.co.uk

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...